Clinical trial
OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the…
NCT02736175 · Ocular Therapeutix, Inc., Industry · Completed
Key facts
| NCT number | NCT02736175 |
|---|---|
| Title | OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery |
| Official title | A Prospective, Multicenter, Randomized, Parallel-Arm, Double-Masked, Vehicle Controlled Phase 3C Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery |
| Lead sponsor | Ocular Therapeutix, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Post-Surgical Ocular Pain, Post-Surgical Ocular Inflammation |
| Intervention type | Drug, Other |
| Interventions | Dexamethasone, Placebo Vehicle |
| Enrollment | 438 |
| Start date | Oct 1, 2015 |
| Primary completion | May 1, 2016 |
| Completion | Jul 1, 2016 |
| First posted | Apr 13, 2016 |
| Last update posted | Nov 13, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: